Skip to main content
Premium Trial:

Request an Annual Quote

But If the Patent Generates $1 Million, Maybe It's a Wash

Over at Genomics, Evolution, and Pseudoscience, Steven Salzberg blogs about Robert Gallo and the Case of the Lost Nobel (as GTO likes to think of it). According to Salzberg, Gallo's snub for the prize this year may be traced back to the disputes on HIV-related patents. The events led to something of an international brouhaha. " If Gallo - whose work was all publicly funded by his employer, the NIH - simply hadn't filed for a patent, who knows how things would have turned out?" writes Salzberg.

 

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.